Upcoming Events
Log In
Pricing
Free Trial

Wk 1, Case 4 - Review

HIDE
PrevNext

0:00

This was an example of a patient that had bilateral

0:05

enhancing lesions involving both orbits.

0:09

And if you look at this image here on the left hand side, um, Courtney,

0:13

you can see my, uh, arrow, right? Yes. Okay.

0:16

So you can see this abnormal enhancement. This abnormal enhancement is,

0:20

it's actually within the muscle cone itself. So this would,

0:23

if you will be a true intracon lesion. And then on the right hand side,

0:28

a part of this is intracon, but there's also a part that's if you will,

0:32

extending extra conal and also involving the medial portion of the,

0:35

of the orbit. Now, in this particular case, um,

0:40

there are a couple things that can give you this differential diagnosis.

0:43

So there's, when I work through a case like this,

0:47

the things that I start to think about are my differential would be, um,

0:52

lymphoma, I would think of pseudotumor.

0:56

I would think of IgG four associated disease. I would think of sarcoidosis.

1:01

And then I would think of,

1:02

of what we used to call Wagners is poly polyangiitis, granulomatosis,

1:08

um, s So those are the things that, that I would think about. Now,

1:12

how can we help kind of separate those two out?

1:16

So what I like to do is try to get as much history as I can. And if,

1:20

if I know the patient, ha if the patient has a lot of orbital pain,

1:24

like really screaming orbital pain along with chemosis,

1:27

then that's gonna drive me to the diagnosis of, of pseudotumor.

1:32

Now, I think there is a D W I sequence in here. Uh,

1:36

so lemme pull that up. D diffusion weighted sequences.

1:41

What's sort of like the cur what's in vogue right now is that if you look at the

1:44

a d C maps, and let me find the a d C maps here,

1:48

I think they're in here somewhere. Uh, let's see.

1:52

There it is. So if you look at the a d C maps,

1:59

you can see that the A d C oh no, it's very sensitive.

2:04

There we go. Um, you can see that there's actually low signal on the A D C.

2:09

So what has been written is that lymphoma is associated with

2:14

reduced a d C. Now,

2:17

what I wanna make sure that you understand as a following is that if you see any

2:21

orbital lesion and there's decreased a d c,

2:23

that does not necessarily mean that the abnormality is lymphoma.

2:27

But if you are considering lymphoma and the a d C is reduced,

2:31

and that is supportive of the diagnosis of lymphoma, because if, for instance,

2:35

if this was metastasis, this would also have a decreased a D C,

2:40

but clinically the patient has no history of a primary lesion and there's no

2:44

concern about metastases,

2:46

then this decreased a d c can lead to your differential diagnosis

2:51

that you're dealing with, that you're dealing with lymphoma.

2:54

So in this particular case, um, this was an example

2:59

Of lymphoma. So what I want to do is, um,

3:04

give you a, a quick, uh, again, a little five, five,

3:07

a couple minute thing on some of these lesions, uh, lymphoma and pseudotumor,

3:13

et cetera. So let me bring up that PowerPoint. So when we start to,

3:17

to look at, I think I just showed this slide here again,

3:20

this was that thyroid ophthalm osteopathy versus the pseudotumor. And again,

3:24

we talked about this pseudotumor compared to thyroid, ophthalm osteopathy,

3:28

it tends to involve the muscle tendon. Now, one of the things, let go back,

3:32

let me go back to this one here. So, sorry, this is,

3:35

this is actually where I wanted to be here. So this,

3:38

these are examples of lymphoma. So how do we kind of make the,

3:42

the diagnosis of lymphoma? So I can tell you in my, in my practice, so you know,

3:46

I have an academic practice and, and a clinical practice. And the most common

3:52

entity that I've seen involving the retrobulbar region, the community.

3:56

So if you're not in an academic practice,

3:58

but you're in a community and you see something like this,

4:01

the most common thing that I've actually run into is lymphoma.

4:05

So lymphoma tends to be, um, densely enhancing on ct.

4:09

It can give you this sort of iso intense, uh, uh, intermediate attenuation.

4:14

And what it tends to do also, it sort of surrounds the nerve.

4:17

Now it doesn't necessarily compress the nerve,

4:20

but it sort of surrounds the nerve.

4:22

And you can see how it's sort of infiltrative,

4:24

it's sort of infiltrating this in the sense it kind of seeps into all the small

4:28

little crevices and there's not really any associated with bone erosion,

4:33

uh, with it. So this is the a d C value, and you can see there's decreased a d,

4:38

C. And if you see that, then that can suggest that you're dealing with lymphoma.

4:42

Now, when it comes to pseudotumor,

4:44

there's actually different types of pseudotumor. And this is where for me,

4:48

it gets a little bit confusing in the sense that pseudotumor,

4:53

the entity has been around for a long time. And from a pathological standpoint,

4:57

when they use the term pathologists, use the term pseudotumor.

5:00

Oftentimes they're not really sure what it is.

5:03

And sometimes if they're not sure what it is,

5:05

they'll go ahead and call it pseudotumor. Now,

5:08

pseudo tumors can be classified based on the morphology that we see

5:13

on imaging.

5:14

So there's actually six types of pseudo tumors based on the morphology.

5:19

So if we have a pseudotumor that's involving the lateral rectus muscle,

5:22

then this is referred to as myotic pseudotumor.

5:26

If we have pseudotumor here that's actually involving the sclera,

5:30

then this would be, uh, sclerotic neut pseudotumor.

5:34

If you have the pseudotumor that's involving the nerve and surrounding the

5:37

nerve, then this would be considered perine retic pseudotumor.

5:41

If it involves the lacrimal gland as it seen here,

5:43

this would be the ral type of pseudotumor.

5:45

If it's kind of involving everything in the orbit,

5:48

this is sometimes referred to as a diffuse pseudotumor. And then, um,

5:52

then if you, um, have pseudotumor that's extending into the cavernous

5:56

Sinus, then this is what we refer to as OSA hunt.

6:00

So there's actually six different types of pseudotumor just based on the

6:04

morphology and the extension.

6:07

And these patients typically present with a lot of orbital pain.

6:12

Now, this disease entity is IgG four associated disease. And again,

6:16

this was sort of, kind of came into vogue in the mid two, 2000 tens.

6:21

Between 2010 and 2020,

6:24

we became aware of this IgG four associated disease. Now,

6:28

this is a distinct entity. Um,

6:31

it's the way you make the diagnosis is through histological analysis,

6:36

and it's unclear whether this is a primary disease or versus a response.

6:40

And about 25 to 50% of quote unquote pseudotumor is

6:45

actually IgG force associated disease.

6:48

And typically the symptoms are painless and an enlarging mass.

6:52

And so many of these things in the head and neck that we would call pseudotumor

6:57

or things like T'S disease or kuttner's disease, um,

7:01

these are now sometimes felt to be as due to IgG four associated disease.

7:05

So even things like Hashimoto's. But the, the,

7:09

the thing that I notice, um, when I compare an academic versus a a,

7:14

a private practice is that if you're in an academic institution,

7:18

the disease sometimes is already considered.

7:21

So they will go ahead and test for, um,

7:25

they will go ahead and test for IgG four in the serum levels.

7:29

But oftentimes in the community,

7:31

what I end up seeing is that I'll call up the ophthalmologist and I'll say, Hey,

7:35

you know, what did the path turn out to be? And they say, well,

7:37

it was two pseudotumor. And then I'll say, well, did you test for IgG four?

7:41

And they said, no,

7:42

we didn't test for IgG four because that's not in our regular armamentarium.

7:46

So my point is that if you do see the path come back as pseudotumor,

7:50

one of the things that you should always ask for is did they actually test for

7:55

IgG four associated disease? So these are all forms of pseudotumor.

7:59

This is pseudotumor that was involved in the medial rectus,

8:02

the superior oblique, and, and the superior rectus.

8:05

This was pseudotumor involving the, uh, lacrimal glands.

8:09

And this was pseudotumor extending into the orbital apex,

8:12

into the cavernous sinus, and then also had this, this, this dural involvement.

8:17

So, uh, I think we did have a question here.

8:19

I think the question was how did dcra cystitis versus lacrimal pseudotumor how

8:24

to differentiate? Um, so javid, it's a great question. Um,

8:30

just based on the imaging findings alone,

8:32

it's really hard to differentiate between quote unquote dcra cystitis will be,

8:37

which will be an inflammation versus lacrimal pseudotumor.

8:40

The way that you can differentiate is potentially based on how the patients

8:45

present if they have pain. So in general, if they have a lot of orbital pain,

8:49

that would be suggestive of lacrimal pseudotumor. But if it's dcra cystitis,

8:54

then

8:54

They may not have as much pain. The other thing that, um,

8:59

that I have seen is that if you true have a two D acro cystitis,

9:04

which is involving the lacog gland,

9:06

then it really should be isolated to the lacm gland as

9:11

opposed to pseudotumor, which can be multifocal.

9:15

So what I would do is make sure you look at your search pattern and you look for

9:19

multiple foci, because if you have multiple foci of this abnormality,

9:23

then that would mean more consistent with, um,

9:26

pseudotumor as opposed to daco cystitis. Um,

9:30

can pseudotumor cause venous thrombosis? So another good question.

9:34

So

9:37

I would say that pseudotumor can probably cause compression of the venous sinus,

9:42

but if you actually look of the occlusion or

9:47

thrombus within the superior ophthalmic vein,

9:50

as you would see in something like cavernous sinus thrombosis,

9:53

and I don't think pseudotumor causes that because pseudotumor is more of a,

9:58

a slow term progressive process as opposed to an acute process.

10:02

So I think if there is anything that's involving the superior thalmic vein,

10:06

it probably would be more chronic as opposed to acute.

10:11

Okay, good. Yeah. So, uh, yeah, that's a really great question.

10:14

I'm glad you've mentioned that. So are there any ways to tell, and,

10:17

and the answer is yes. So let me, um,

10:21

let me get out of this and, and I'll show you exactly what I mean.

10:25

So when you show the case of,

10:28

of lymphoma in this particular case,

10:31

yes it does sort of look like meningioma, but if you look at the Coronas, no,

10:35

notice how this is a little bit more extensive.

10:38

But the real thing well I want you to pay attention to,

10:41

and I'm glad you asked the question,

10:42

is that the caliber of the optic nerve in lymphoma tends to

10:47

be preserved. And again,

10:49

the only way I can tell you this is sort of like looking at this over many

10:52

years, but lymphoma, again,

10:55

it's not really a hard compressive lesion because it's a rounding.

10:58

It's really arising from the soft tissues within the orbit itself.

11:04

Now if I go back and I look at this case,

11:08

so this is an example again of a retrobulbar mass that really looks sausage

11:12

shaped and you say to yourself, well this could be an optic nerve glioma,

11:16

could it be meningioma, could it be lymphoma, et cetera.

11:19

But this actually turns out to be meningioma.

11:22

Now the thing about the meningioma is that you've heard about the tram track

11:25

sign. So what meningiomas do is that they actually arise from the dural sheets

11:30

surrounding the orbit and they compress the optic nerve.

11:33

So notice how the optic nerve is actually compressed. So for me,

11:37

the way that I can differentiate meningioma from other entities

11:42

such as this, so this is an example of sarcoidosis, is yes,

11:46

there is enhancement here involving the C S F and the dura,

11:50

but notice how the caliber of the optic nerve

11:52

Is maintained. So for me, the key thing is to look at the caliber.

11:56

And if I see something that's involved in the optic nerve,

11:58

but that underlying optic nerve is narrowed,

12:02

then that's how I suggest a diagnosis of meningioma.

12:05

There was one case that, um,

12:08

that I've seen that was called lymphoma,

12:11

but it actually turned out to be meningioma.

12:13

You could actually tell because the nerve sheath was the,

12:15

the optic nerve was narrowed. So hopefully that answered your question.

12:20

I wouldn't make a list of everything that's decreased a, D, C,

12:23

and then start off with the A D C, I would suggest

12:28

coming up with what you think the diagnosis is based on the

12:33

non a d C images

12:36

and then see if the a d C is supportive of any of those entities.

12:42

Because what ends up happening is that you sort of focus on one sequence and the

12:46

next thing you know, you're like, well, 10 things can be, have decreased a, D,

12:51

C, and then you get confused.

12:53

So I always use a d c as a more confirmatory sequence as opposed to the primary

12:58

sequence. So the thing about things like chondro sarcoma, yeah,

13:02

chondro sarcomas can be low on a d c,

13:05

but is that because the density of the cells is really dense or is it because of

13:09

the calcification? And then then you'll say, well, you know what,

13:13

what about chondro? What about uh,

13:16

mixed con chondro sarcomas that have more of a chordoma

13:20

matrix?

13:21

'cause they can be mixed and then all of a sudden you kind of get confused

13:24

because these are not homogeneous tumors.

13:27

So I always use a d C as confirmatory.

13:29

So I look at everything else and then in the back of my mind, I know, well,

13:33

an abscess can have restricted diffusion and I know that more aggressive tumors

13:38

can have restricted diffusion. So if I'm looking at something and I'm like, Hmm,

13:43

there's the mass, what are the, all the imaging characteristics? And I'm,

13:46

I'm still trying to figure out, hmm, could this be benign or malignant?

13:49

Then I look at the ADCs and if it's decreased a D C and it's a good quality a c

13:53

c, then that drives me to suggest that I'm looking at more of a malignancy.

Report

Patient History
Blurred vision.

Findings
There are bilateral enhancing lesions involving both orbits. There is a large enhancing left retrobulbar mass that abuts the posterior aspect of the sclera. This diffusely enhancing mass surrounds the left optic nerve and peripherally displaces the medial and inferior rectus muscles. The mass extends inferiorly and encases the left inferior rectus muscle. There does appear to be some thickening involving the left eyelid.

There is also a diffuse enhancing lesion involving the right orbit. This diffusely enhancing masses involves the retrobulbar region and extends medially to involve the medial rectus muscle. The mass extends superiorly and encases the superior rectus and superior oblique muscles. There is retrobulbar extension of the mass. The lesion abuts the superior aspect of the right optic nerve but does not have the degree of encasement of the left optic nerve as seen on the contralateral side.

The above abnormality has increased DWI signal associated with reduced ADC suggestive of a densely cellular and possibly malignant process.

No abnormal sellar or juxtasellar enhancing lesions are seen. No evidence of compressive lesions are identified involving the optic chiasm. No abnormal lesions are identified involving the anterior skull base or olfactory sulcus. The bilateral gyrus rectus are normal. No evidence of aggressive skull base lesions are seen. No abnormal enhancing lesions are identified in the region of the perimesencephalic cistern. The fat in the bilateral pterygopalatine fossa is symmetric and within normal limits. No definite evidence of aggressive lesions are identified within either cavernous sinus or Meckel's cave.

Conclusions
1. Diffuse bilateral enhancing orbital masses associated with increased DWI signal and reduced ADC. These findings are most consistent with lymphoma. Another differential consideration is IgG4 associated disease. This patient does not have the clinical symptoms that would suggest orbital pseudotumor. There is no history of malignancy which makes metastasis unlikely.
2. No evidence of abnormal enhancing lesions involving either Meckel's cave.

Case Discussion

Faculty

David M Yousem, MD, MBA

Professor of Radiology, Vice Chairman and Associate Dean

Johns Hopkins University

Suresh K Mukherji, MD, FACR, MBA

Clinical Professor, University of Illinois & Rutgers University. Faculty, Michigan State University. Director Head & Neck Radiology, ProScan Imaging

Tags

Neuroradiology

MRI

Head and Neck